SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-21-004513
Filing Date
2021-04-20
Accepted
2021-04-20 16:49:06
Documents
4
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20210615xdef14a.htm DEF 14A 640465
2 GRAPHIC tmb-20210615xdef14a012.jpg GRAPHIC 108172
3 GRAPHIC tmb-20210615xdef14a001.jpg GRAPHIC 8799
4 GRAPHIC tmb-20210615xdef14a013.jpg GRAPHIC 136997
  Complete submission text file 0001558370-21-004513.txt   991627
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37719 | Film No.: 21838508
SIC: 2834 Pharmaceutical Preparations